序号 |
标题 |
次数 |
作者 |
发布时间 |
226 |
DOPG:DOPC (1:99)阴离子脂质体 DOPG:DOPC (0.5:99.5) Anionic Liposomes |
3 |
axc |
2024-12-20 |
227 |
Azido-PEG3-Val-Cit-PAB-OH, CAS号:2055024-65-0 |
2 |
WYQ |
2024-12-20 |
228 |
DBCO-PEG4-GGFG-DX8951 抗体-药物偶联物(ADC) |
3 |
zyl |
2024-12-20 |
229 |
DBCO-Val-Cit-PAB-MMAE ,CAS号:2768446-73-5 |
2 |
WYQ |
2024-12-20 |
230 |
HS-(CH2)11-PEG4-OH |
6 |
h |
2024-12-20 |
231 |
Azido-PEG4-Val-Cit-PAB-MMAE,1869126-64-6 |
3 |
WYQ |
2024-12-20 |
232 |
NHS-PEG8-NH-Xanomeline 抗体-药物偶联物(ADC) |
4 |
zyl |
2024-12-20 |
233 |
DOPC:Chol:DOPS:peg 2000-DOPE(60:30:5:5),聚乙二醇化阴离子脂质体 |
3 |
axc |
2024-12-20 |
234 |
Azido-PEG4-MMAE, CAS号:1869126-64-6 |
4 |
WYQ |
2024-12-20 |
235 |
MA-Gly-GlcA-Exatecan-ADC连接子 |
8 |
zyl |
2024-12-20 |
236 |
CAS: 2762518-86-3,NHS Ester-PEG4-Val-Cit-PAB-MMAE |
7 |
WYQ |
2024-12-20 |
237 |
(R)-8-N3-2-(Fmoc-amino)octanoic acid,抗体药物偶联物(ADC) |
4 |
kx |
2024-12-20 |
238 |
DSPC:Chol:DSPS:peg 2000-DSPE(60:30:5:5),聚乙二醇化阴离子脂质体 |
3 |
axc |
2024-12-20 |
239 |
MC-VC-PAB-DMEA (PEG2)- Duocarmycin SA |
8 |
zyl |
2024-12-20 |
240 |
m-PEG3-CH2-alcohol,CAS号100688-48-0 |
3 |
wyh |
2024-12-20 |
241 |
CAS: 1492056-71-9,Amino-PEG4-Val-Cit-PAB-MMAE |
6 |
WYQ |
2024-12-20 |
242 |
N3-PEG3-vc-PAB-MMAE |
4 |
zyl |
2024-12-20 |
243 |
CAS: 1350456-56-2,Fmoc-Val-Cit-PAB-MMAE |
2 |
WYQ |
2024-12-20 |
244 |
MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH |
2 |
wyh |
2024-12-20 |
245 |
DSPC:Chol:DOPG:peg 2000-DSPE(60:30:5:5),聚乙二醇化阴离子脂质体 |
4 |
axc |
2024-12-20 |
246 |
Ac-Val-Leu-Pro-Glu(OMe)-CH2F |
3 |
h |
2024-12-20 |
247 |
CAS: 2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH |
4 |
WYQ |
2024-12-20 |
248 |
GGFG-AM-Dxd |
3 |
zyl |
2024-12-20 |
249 |
DSPC:Chol:DSPG:peg 2000-DSPE(60:30:5:5),聚乙二醇化阴离子脂质体 |
5 |
axc |
2024-12-20 |
250 |
4-Ketobenzotriazine-O-CH2-COOH |
2 |
h |
2024-12-20 |
251 |
GG-PEG4-EDA-PNU |
4 |
zyl |
2024-12-20 |
252 |
cas:112-27-6,Triethylene glcol,三甘醇 |
3 |
kx |
2024-12-20 |
253 |
CAS: 2112738-13-1,Mal-amido-PEG2-Val-Cit-PAB-PNP 基本信息 |
3 |
WYQ |
2024-12-20 |
254 |
H2N-PEG12-CH2CH2NH2 |
4 |
h |
2024-12-20 |
255 |
CAS: 2112738-09-5,Mal-PEG4-Val-Cit-PAB-PNP |
2 |
WYQ |
2024-12-20 |
256 |
Ald-C2-PEG4-azide |
5 |
h |
2024-12-20 |
257 |
cas:1438415-89-4,TCO-PNB ester,抗体药物偶联物(ADC) |
3 |
kx |
2024-12-20 |
258 |
DBCO-PEG4-VC-PAB-DMEA-PNU159682,CAS:2259318-56-2 |
4 |
zyl |
2024-12-20 |
259 |
N3-PEG16-CH2CH2COOH |
3 |
h |
2024-12-20 |
260 |
HO-PEG16-CH2CH2COOH |
3 |
h |
2024-12-20 |
261 |
叶酸修饰的脂质体,FA-Lips,定制服务 |
3 |
axc |
2024-12-20 |
262 |
cas:55750-62-4,3-Maleimido-propionic NHS ester, 3-马来酰亚胺丙酸 N-羟基琥珀酰亚胺酯 |
3 |
kx |
2024-12-20 |
263 |
mDPR-VC-PAB-MMAE |
5 |
zyl |
2024-12-20 |
264 |
Hydroxy-PEG10-acid |
3 |
h |
2024-12-20 |
265 |
Fmoc-PEG2-C2-NHS ester |
7 |
h |
2024-12-20 |
266 |
叶酸修饰红细胞膜-杂合脂质体,RCM-FA-Lips,定制服务 |
3 |
axc |
2024-12-20 |
267 |
cas:57078-99-6,5-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acid,5-马来酰亚胺戊酸 |
4 |
kx |
2024-12-20 |
268 |
Cl-C6-PEG4-O-CH2COOH |
2 |
h |
2024-12-20 |
269 |
Bis-CH2-PEG2-acid |
8 |
wyh |
2024-12-20 |
270 |
Ac-PLVE-FMK |
8 |
h |
2024-12-20 |